Trump Orders CDC to Halve Childhood Vaccines, Igniting Health Debate
President Trump signed an executive order directing the CDC to cut recommended childhood vaccines from 17 to 11, sparking fierce opposition from medical groups.
From the latest clinical research and public health alerts to nutrition advice and mental health insights, get reliable health information to make informed decisions for yourself and your family.
President Trump signed an executive order directing the CDC to cut recommended childhood vaccines from 17 to 11, sparking fierce opposition from medical groups.
The MHRA has recalled a batch of Crescent Pharma ramipril 2.5mg capsules after some boxes were found to contain 10mg tablets. Patients are urged to check their
UK doctors strike for 16th time as NHS faces pay disputes, while global reports highlight US healthcare failures and Europe's systemic challenges.
BCBSM and Michigan Medicine finalize a long-term contract, ensuring in-network access for 300,000 patients and ending months of tense negotiations.
The WHO declares a PHEIC as an Ebola outbreak in DR Congo and Uganda kills at least 80, with cross-border spread raising international alarm.
Experimental drug daraxonrasib doubles survival in advanced pancreatic cancer by targeting the previously undruggable KRAS mutation.
Over 100 passengers and crew fell ill with norovirus on the Caribbean Princess. Experts say cruise safety remains strong despite the outbreak.
A deadly Andes hantavirus outbreak on the MV Hondius cruise ship has killed three. Here's the latest on symptoms, transmission, and global response.
A suspected hantavirus case has been reported on Tristan da Cunha, the world's most remote inhabited island, linked to the MV Hondius cruise ship outbreak.
WHO confirms Andes hantavirus strain on MV Hondius cruise ship. Rare person-to-person transmission suspected as three die and patients are evacuated.
The Terminally Ill Adults (End of Life) Bill expired in the House of Lords on April 24, 2026. Dame Esther Rantzen vows to keep battling for future generations.
The 'Ozempic personality' debate is colliding with new science on GLP-1 drugs, mood changes, and a Stanford-backed alternative. What researchers now know.